EFFECTS OF CHOLINERGIC DRUGS ON GENETIC ABSENCE SEIZURES IN RATS

Citation
L. Danober et al., EFFECTS OF CHOLINERGIC DRUGS ON GENETIC ABSENCE SEIZURES IN RATS, European journal of pharmacology, 234(2-3), 1993, pp. 263-268
Citations number
42
ISSN journal
00142999
Volume
234
Issue
2-3
Year of publication
1993
Pages
263 - 268
Database
ISI
SICI code
0014-2999(1993)234:2-3<263:EOCDOG>2.0.ZU;2-0
Abstract
Wistar rats of a selected strain show spontaneous generalized non-conv ulsive seizures with bilateral synchronous spike-wave discharges on th e cortical electroencephalograph (EEG). The 7 to 9 c/s spike-wave disc harges occur predominantly in waking states of inactivity. The effects of cholinergic drugs on the cumulated duration of spike-wave discharg es were investigated in this rat model of absence epilepsy. I.p. injec tions of drugs which potentiate cholinergic neurotransmission, namely the acetyl-cholinesterase inhibitor, physostigmine (0.1-0.5 mg/kg), th e muscarinic receptor agonists, oxotremorine (0.25-1 mg/kg) and piloca rpine (0.125-2 mg/kg), and the nicotinic receptor agonist, nicotine (0 .062-2 mg/kg), suppressed discharges in a dose-dependent manner and in duced an arousal-like cortical EEG. The muscarinic receptor antagonist , scopolamine, increased the spike-wave discharges at doses below 0.05 mg/kg; at higher doses (0.05-1 mg/kg) it decreased discharges and ind uced a sleep-like EEG. The nicotinic receptor antagonist, mecamylamine (0.5-6 mg/kg), had no effect on spike-wave discharges or the EEG. The se results suggest that cholinergic activity accounts for the preferen tial occurrence of absence seizures in states of reduced arousal.